Welcome to our dedicated page for Aptargroup SEC filings (Ticker: ATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AptarGroup, Inc.'s SEC filings document operating results, governance matters and capital-structure activity for a NYSE-listed maker of drug delivery and consumer-product dispensing technologies. Form 8-K reports furnish quarterly and annual results, segment commentary for Pharma, Beauty and Closures, shareholder returns and material events tied to the company's operations.
The filing record also includes proxy materials and annual meeting vote results covering director elections, advisory compensation matters and stockholder voting items. Capital disclosures include common stock registered under the Exchange Act, shelf-registration activity and completed debt financing, including the 4.750% Senior Notes due 2031 issued under an indenture.
APTARGROUP, INC. Executive Vice President and Chief Legal Officer Irene Elizabeth Hudson reported an exercise-and-sell transaction in company stock. She exercised stock options for 842 shares of common stock at $111.38 per share and sold a total of 1,264 common shares in open-market trades at weighted average prices of $123.4508 and $123.3812 per share, with individual trades executed within stated price ranges. Following these transactions, she holds 1,480 common shares directly.
Marey-Semper Isabel reported acquisition or exercise transactions in this Form 4 filing.
APTARGROUP, INC. director Isabel Marey-Semper received a grant of 1,326 shares of common stock on May 6, 2026 as a compensation-related award, at a stated price of $0.00 per share. Following this grant, she directly owns 9,670 shares of AptarGroup common stock.
Kampouri Monnas Giovanna reported acquisition or exercise transactions in this Form 4 filing.
APTARGROUP, INC. director Giovanna Kampouri Monnas received a grant of 1,326 shares of Common Stock on May 6, 2026. The award was recorded at a price of $0.00 per share, indicating it was a compensation-related grant rather than a market purchase. Following this award, she directly holds a total of 9,977 common shares.
Owens B Craig reported acquisition or exercise transactions in this Form 4 filing.
APTARGROUP, INC. director B. Craig Owens received a stock grant of 1,326 shares of Common Stock, reported at a price of $0.00 per share, indicating a compensation-related award rather than a market purchase. Following this grant, he directly holds 11,082.592 AptarGroup shares.
APTARGROUP, INC. director Sarah JS Glickman received a grant of 1,326 shares of Common Stock on May 6, 2026. The shares were acquired at a stated price of $0.0000 per share, indicating a compensation-related award rather than an open-market purchase. Following this grant, her direct ownership increased to 4,402 Common Stock shares.
APTARGROUP, INC. director George L. Fotiades reported receiving a stock award of 1,326 shares of Common Stock on May 6, 2026. The award was recorded at a price of $0.00 per share, indicating a non-cash grant classified as a “Grant, award, or other acquisition.”
Following this transaction, Fotiades directly owned 6,295 shares of AptarGroup common stock, as reported in the filing. The Form 4 shows no stock sales or option exercises, only this equity grant increasing his direct shareholdings.
APTARGROUP, INC. director Matthew L. Trerotola received an award of 1,326 shares of common stock on May 6, 2026. The shares were acquired at a stated price of $0.00 per share as a grant, not an open‑market purchase. Following this award, his direct holdings total 9,155.85 shares of common stock.
Wunderlich Ralf K. reported acquisition or exercise transactions in this Form 4 filing.
APTARGROUP, INC. director Ralf K. Wunderlich received a grant of 1,326 shares of Common Stock on May 6, 2026. The award was recorded at a price of $0.0000 per share, indicating a compensation-related stock grant rather than a market purchase. After this transaction, Wunderlich directly owns 18,539 shares of AptarGroup common stock.
Xing Julie reported acquisition or exercise transactions in this Form 4 filing.
APTARGROUP, INC. director Julie Xing received a grant of 1,326 shares of Common Stock on May 6, 2026. The shares were awarded at a reported price of $0.00 per share, indicating a compensation-related grant rather than an open-market purchase. After this award, Xing directly holds 5,091 common shares. This is a routine equity compensation transaction and does not reflect a discretionary market trade.
Matthews Candace S. reported acquisition or exercise transactions in this Form 4 filing.
APTARGROUP, INC. director Candace S. Matthews received a grant of 1,552 shares of Common Stock on May 6, 2026. The shares were awarded at a stated price of $0.00 per share, reflecting equity compensation rather than a market purchase. Following this award, she directly holds a total of 7,875 common shares. This filing records a routine stock grant to a board member, with no open-market buying or selling activity disclosed.